RECRUITINGOBSERVATIONAL
A Study on the Preference of Risperidone Dosage Forms
About This Trial
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.
Who Should NOT Join This Trial:
- Have difficulty reading and understanding Chinese or refuse to participate in the study.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.
Exclusion Criteria:
* Have difficulty reading and understanding Chinese or refuse to participate in the study.
Locations (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China